FDA Tightens Cybersecurity Regulations for Medical Devices
The FDA now mandates that medical device manufacturers include a SBOM for cybersecurity compliance under FD&C Act.
The FDA now mandates that medical device manufacturers include a SBOM for cybersecurity compliance under FD&C Act.
Pulse Biosciences announced that the FDA granted 510(k) clearance for its CellFX nsPFA Percutaneous Electrode System.
Philips has recalled its BrightView SPECT imaging systems for a potential component failure that would cause parts to fall on the patient.
Nanowear has received U.S. FDA 510(K) clearance for its AI-enabled Software-as-a-Medical Device called SimpleSense, which includes a non-invasive continuous blood pressure monitor for clinical diagnostic management of hypertension.
ResMed Ltd is recalling all its CPAP masks with magnets due to possible magnetic interference with certain medical devices.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The FDA is establishing a Digital Health Advisory Committee in 2024, comprising experts from various fields, to advise on the safe and effective regulation of digital health technologies like AI, virtual reality, and wearables, aiming to promote innovation while safeguarding public health.